Extra Pfizer/BioNTech and Moderna jabs for 2022 and 2023 ordered to ‘future proof’ vaccine programme
Ministers in the UK have secured new contracts to buy 114m more Covid-19 vaccines for the next two years.
The deals, for 2022 and 2023, were accelerated after the emergence of the Omicron coronavirus variant, officials said. Under the agreements, the UK will buy 54m more doses from Pfizer/BioNTech and 60m more doses from Moderna.